Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 11;9(1):8494.
doi: 10.1038/s41598-019-44916-7.

Analytical Exploration of Potential Pathways by which Diabetes Mellitus Impacts Tuberculosis Epidemiology

Affiliations

Analytical Exploration of Potential Pathways by which Diabetes Mellitus Impacts Tuberculosis Epidemiology

Susanne F Awad et al. Sci Rep. .

Abstract

We aimed to develop a conceptual framework of diabetes mellitus (DM) effects on tuberculosis (TB) natural history and treatment outcomes, and to assess the impact of these effects on TB-transmission dynamics. The model was calibrated using TB data for India. A conceptual framework was developed based on a literature review, and then translated into a mathematical model to assess the impact of the DM-on-TB effects. The impact was analyzed using TB-disease incidence hazard ratio (HR) and population attributable fraction (PAF) measures. Evidence was identified for 10 plausible DM-on-TB effects. Assuming a flat change of 300% (meaning an effect size of 3.0) for each DM-on-TB effect, the HR ranged between 1.0 (Effect 9-Recovery) and 2.7 (Effect 2-Fast progression); most effects did not have an impact on the HR. Meanwhile, TB-disease incidence attributed directly and indirectly to each effect ranged between -4.6% (Effect 7-TB mortality) and 34.5% (Effect 2-Fast progression). The second largest impact was for Effect 6-Disease infectiousness at 29.9%. In conclusion, DM can affect TB-transmission dynamics in multiple ways, most of which are poorly characterized and difficult to assess in epidemiologic studies. The indirect (e.g. onward transmission) impacts of some DM-on-TB effects are comparable in scale to the direct impacts. While the impact of several effects on the HR was limited, the impact on the PAF was substantial suggesting that DM could be impacting TB epidemiology to a larger extent than previously thought.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
List of the key research questions assessed in this study along with the methods used to address them.
Figure 2
Figure 2
A conceptual framework for the TB-DM epidemiologic synergy. The black lines indicate the transitions within TB’s natural history and treatment states. The red lines indicate the 10 plausible effects of DM on TB natural history and treatment outcomes.
Figure 3
Figure 3
Epidemiological impact of the 10 plausible effects of diabetes mellitus (DM) on tuberculosis (TB) natural history and treatment outcomes, as measured by the incidence hazard ratio (HR) of TB disease among those with DM compared to those without DM. (A) Results of the impact of each of the effects individually. (B) Results of the impact of all possible combinations of the effects that individually had an HR >1.0. Each DM on TB effect had a standardized effect size (ES) of 3.0 if the expected ES (based on evidence) is ≥1, and (an inverse) ES of 1/3 if the expected ES is <1 (red line).
Figure 4
Figure 4
Assessment of varying the effect size of each of the diabetes mellitus (DM) on tuberculosis (TB) effects to yield the observed hazard ratio (HR) of 3.0. HR is defined as the ratio of TB disease incidence rate among those with DM compared to those without DM.
Figure 5
Figure 5
Proportion of tuberculosis (TB) disease incidence (A), prevalence (B), and mortality (C) attributed to each of the effects of diabetes mellitus (DM) on TB natural history and treatment outcomes. These population attributable fraction (PAFTrue) measures were estimated as the proportional reduction in the measure in a comparison between the measure in a scenario where there is TB-DM epidemiologic synergy (that is some effect for DM on TB is active), compared to a counter-factual scenario where there is no TB-DM epidemiologic synergy. Each DM on TB effect had a standardized effect size (ES) of 3.0 if the expected ES (based on evidence) is ≥1, and (an inverse) ES of 1/3 if the expected ES is <1. The red bar (and line) in panel A is the estimated Levin’s formula population attributable fraction, assuming a relative risk (RR) of 3.0 for TB-disease incidence among DM versus non-DM individuals.

References

    1. World Health Organization. Global tuberculosis report 2018 (Available from, http://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng..., accessed Sept. 2018) (2018).
    1. World Health Organization. Global tuberculosis report 2016 (Available from, http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?..., accessed on May 2017) (2016).
    1. World Health Organization. Draft global strategy and targets for tuberculosis prevention, care and control after 2015 (Available at, http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_11-en.pdf?ua=1) (March 2014).
    1. Boucot KR. Diabetes mellitus and pulmonary tuberculosis. J Chronic Dis. 1957;6:256–279. doi: 10.1016/0021-9681(57)90007-3. - DOI - PubMed
    1. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS medicine. 2008;5:e152. doi: 10.1371/journal.pmed.0050152. - DOI - PMC - PubMed

Publication types